InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,700.00
(
-0.02%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
77.90
(
0.56%
)
Bitcoin
64,102.05
(
1.99%
)
Post# of 253357
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: biomaven0 post# 163316

Monday, 07/01/2013 9:26:09 PM

Monday, July 01, 2013 9:26:09 PM

Post# of 253357

I personally have high hopes for a JAK1 drug in autoimmune disease. The basis for this is that inhibiting JAK1 in theory blocks STAT3, which in turn is one of the critical pathways for TH17, which I have come to believe is one of the key players in autoimmunity.

Do you have just as much confidence in the Galapagos JAK1 for Crohn's as you do RA?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up